ChartRow logo
STE
STERIS plc (Ireland)Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.03% · US Stock Market 0.03% · Russell 3000 0.03%
$205.04-1.44%
as of market close, Sep 18, 2026
☾ AH
PeersMRNALLYUNHJNJMRKTMO

STE financial statements

The full income statement, balance sheet, and cash-flow statement for STERIS plc (Ireland) (STE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 98.6M2024-09 98.7M2024-12 98.3M2025-03 98.4M2025-06 98.5M2025-09 98.1M2025-12 98.1M2026-03 97.6M2026-06 97.5M-1.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Revenue5.94B+8.7%5.46B+6.2%5.14B+13.3%4.54B+7.4%4.22B+35.9%
2.63B+9.3%2.40B+8.3%2.22B+12.0%1.98B+5.2%1.88B+40.2%
Cost of revenue3.31B+8.3%3.06B+4.7%2.92B+14.3%2.56B+9.2%2.34B+32.6%
1.52B-0.7%1.54B+11.2%1.38B+16.2%1.19B-15.3%1.41B+76.8%
Research & development113M+4.9%108M+3.8%104M+5.3%98.5M+13.6%86.7M+30.7%
Selling, general & administrative1.41B+5.5%1.33B+6.5%1.25B+14.8%1.09B-17.3%1.32B+80.3%
Restructuring3.40M-94.5%62.3M+40.3%44.4M+9054.6%485K+910.4%48.0K+101.6%
Amortization of intangibles268M-2.9%276M+2.9%268M+3.3%260M-1.9%265M+205.9%
Operating income1.10B+27.1%867M+3.6%836M+5.7%791M+65.6%478M-12.9%
Interest expense60.7M-29.7%86.3M-40.2%144M+33.7%108M+20.6%89.5M+140.7%
Other non-operating income9.80M+16.7%8.40M-23.6%11.0M+482.1%-2.88M-145.8%6.28M-1.0%
Gain (loss) on equity securities200K-77.8%900K-15.1%1.06M+190.1%-1.18M-51.7%-775K-230.5%
Pre-tax income1.05B+31.5%796M+13.3%703M+3.3%680M+85.5%367M-29.1%
Income tax262M+42.0%185M+23.5%150M+20.5%124M+50.7%82.3M-31.8%
782M+27.3%615M+62.5%378M+253.4%107M-56.1%244M-38.6%
Net income to non-controlling interest2.80M+100.0%1.40M-22.2%1.80M+247.9%-1.22M-19.5%-1.02M-92.1%
$7.93+27.9%$6.20+62.7%$3.81+256.1%$1.07-56.9%$2.48-46.4%
EPS (basic)$7.97+27.7%$6.24+62.9%$3.83+257.9%$1.07-57.2%$2.50-46.4%
Weighted-avg shares (basic)98.2M-0.4%98.6M-0.2%98.8M-0.9%99.7M+2.2%97.5M+14.5%
Weighted-avg shares (diluted)98.7M-0.4%99.1M-0.3%99.4M-0.8%100M+2.0%98.3M+14.5%
Dividends per share$2.46+10.3%$2.23+9.9%$2.03+10.3%$1.84+8.9%$1.69+7.6%
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
2.39B+19.7%2.00B-30.3%2.87B+42.6%2.01B+7.0%1.88B+55.1%
Cash & equivalents440M+156.0%172M-17.1%207M-0.6%208M-40.2%348M+57.9%
Accounts receivable1.09B+4.7%1.04B+3.5%1.01B+16.6%865M+8.3%799M+31.1%
Inventory632M+8.7%581M-13.8%675M+11.6%604M+5.1%575M+82.5%
10.7B+5.8%10.1B-8.3%11.1B+2.2%10.8B-5.3%11.4B+73.8%
Property, plant & equipment2.16B+10.5%1.96B+10.8%1.77B+8.1%1.63B+5.2%1.55B+25.7%
Operating lease right-of-use155M-0.8%156M-9.7%173M+4.0%167M-11.6%188M+25.5%
Goodwill4.19B+2.4%4.10B+0.6%4.07B+4.9%3.88B-1.5%3.94B+30.2%
Intangible assets1.62B-12.6%1.85B-12.5%2.12B+2.1%2.08B-37.6%3.33B+270.5%
Other non-current assets211M+154.7%83.0M+25.4%66.2M-15.0%77.9M+10.2%70.7M+34.0%
1.15B+12.0%1.02B+9.8%931M+8.0%862M-6.5%922M+59.6%
Accounts payable339M+20.7%281M+11.6%252M-4.7%264M+17.0%226M+43.8%
Accrued liabilities402M+9.2%368M+15.1%320M+7.3%298M-2.8%307M+39.0%
Short-term & current debt119M-4.9%125M+45.5%85.9M+43.2%60.0M-58.0%143M
Current lease liability35.8M+4.7%34.2M+9.5%31.2M+3.9%30.1M-17.6%36.5M+60.1%
3.54B+0.3%3.53B-25.6%4.75B+0.3%4.73B-3.0%4.88B+81.8%
Long-term debt1.81B-5.5%1.92B-38.5%3.12B+3.4%3.02B+2.5%2.95B+78.5%
Non-current lease liability120M-4.0%125M-14.6%146M+4.5%140M-10.0%155M+19.6%
Other non-current liabilities71.7M+15.8%61.9M-13.5%71.5M-6.0%76.1M+0.7%75.6M-14.1%
7.18B+8.8%6.60B+4.8%6.30B+3.7%6.08B-7.0%6.53B+68.3%
Common stock4.28B-3.2%4.42B-2.7%4.54B+1.3%4.49B-5.4%4.74B+136.8%
Retained earnings3.02B+21.8%2.48B+18.6%2.09B+9.2%1.91B-4.4%2.00B+3.1%
Accumulated other comprehensive income-113M+61.3%-292M+11.1%-329M-2.5%-321M-52.9%-210M-242.6%
Non-controlling interest13.6M+9.7%12.4M-5.9%13.2M+32.2%9.97M-18.8%12.3M+17.2%
Total equity incl. non-controlling7.20B+8.8%6.62B+4.8%6.32B+3.7%6.09B-7.0%6.54B+68.2%
Total liabilities & equity10.7B+5.8%10.1B-8.3%11.1B+2.2%10.8B-5.3%11.4B+73.8%
Common shares issued97.8M-0.5%98.3M-0.6%98.9M+0.3%98.6M-1.4%100M+17.2%
Common shares outstanding97.8M-0.5%98.3M-0.6%98.9M+0.3%98.6M-1.4%100M+17.2%
Shares outstanding (cover)97.6M-0.8%98.4M-0.5%98.9M+0.3%98.7M-1.4%100M+17.2%
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
1.34B+16.8%1.15B+18.0%973M+28.6%757M+10.5%685M-0.7%
Depreciation & amortization487M+2.2%476M-15.7%565M+2.2%553M-0.0%553M+152.3%
Intangible amortization268M-2.9%276M+2.9%268M+3.3%260M-1.9%265M+205.9%
Share-based compensation61.7M+7.5%57.4M+1.6%56.5M+45.1%39.0M-32.4%57.7M+122.1%
Deferred income taxes-16.9M+77.9%-76.5M+41.8%-131M+29.3%-186M-74.4%-107M-2614.6%
Change in receivables25.1M-12.8%28.8M-77.5%128M-3.9%133M+156.5%52.0M+530.3%
Change in inventory24.0M+132.8%-73.1M-294.9%37.5M-69.7%124M+20.4%103M+2830.8%
Change in payables51.1M+52.1%33.6M+276.8%-19.0M-135.6%53.3M+258.3%14.9M+306.4%
-513M-231.8%389M+143.8%-887M-131.5%-383M+42.5%-667M+42.2%
Capital expenditure369M-0.3%370M+2.7%360M-0.5%362M+25.9%288M+20.2%
Free cash flow972M+25.0%778M+26.9%613M+55.2%395M-0.6%397M-11.8%
Acquisitions20.1M-62.8%54.1M-90.1%546M+1183.2%42.6M-92.3%550M-39.5%
Purchases of investments134M+1140.7%10.8M+620.0%1.50M0.000.00-100.0%
Proceeds from sale of PP&E10.5M+14.1%9.20M+24.3%7.40M-49.3%14.6M+737.9%1.74M+206.0%
Other investing activities0.000.00-100.0%
-568M+63.9%-1.57B-1745.5%-85.2M+82.9%-499M-530.6%116M-66.5%
Long-term debt issued0.000.000.000.00-100.0%1.35B
Long-term debt repaid0.000.000.000.000.00-100.0%
Common stock issued0.000.000.000.000.00
Common stock repurchased236M+11.5%211M+1690.7%11.8M-96.2%309M+453.2%55.8M+280.8%
Dividends paid242M+10.0%220M+9.6%201M+9.3%183M+12.5%163M+21.9%
Other financing activities32.9M+29.0%25.5M+142.9%10.5M+474.4%1.83M-81.8%10.1M-62.3%
FX effect on cash7.20M+3500.0%200K+109.5%-2.10M+85.9%-14.9M-136.2%-6.29M-131.7%
Net change in cash268M+858.9%-35.3M-2615.4%-1.30M+99.1%-140M-209.5%128M+229.0%
Interest paid64.7M-27.6%89.4M-37.1%142M+31.1%108M+28.1%84.7M+133.6%
Income taxes paid289M+5.6%274M+0.8%271M+6.5%255M+84.0%138M+26.2%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap21.6B-3.2%22.3B+0.4%22.2B+17.7%18.9B-22.0%24.2B+48.8%
P/E27.6×-24.0%36.3×-7.4%39.2×-77.8%176.3×+77.7%99.2×+142.5%
P/S3.6×-11.0%4.1×-8.1%4.4×+6.8%4.2×-27.4%5.7×+9.5%
P/B3.0×-11.0%3.4×-2.5%3.5×+11.5%3.1×-16.2%3.7×-11.6%
P/FCF22.2×-22.6%28.7×-23.4%37.4×-21.7%47.8×-21.6%60.9×+68.7%
Earnings yield3.6%+31.5%2.8%+8.0%2.6%+349.9%0.57%-43.7%1.0%-58.8%
FCF yield4.5%+29.1%3.5%+30.5%2.7%+27.7%2.1%+27.5%1.6%-40.7%
Dividend yield1.1%+13.1%0.98%+9.0%0.90%-6.1%0.96%+37.6%0.70%-15.2%
Source filing10-K10-K10-K10-K10-K

About this data

Source: STE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all STE filings on SEC EDGAR → Not investment advice.